Chang‐Min Choi

Asan Medical Center

Papers

1

Total Citations

11

H-Index

1

About

Chang‐Min Choi is a leading oncologist and researcher whose work has profoundly shaped the understanding and management of lung cancer, particularly within the Korean population. His key research areas encompass thoracic oncology, cancer epidemiology, and precision medicine, with a major focus on the distinct genetic and environmental factors driving lung cancer in East Asian patients. Choi’s most-cited paper, "Lung Cancer in Korea" (2021), with 11 citations, provides a critical epidemiological overview that has become a foundational reference for clinicians and scientists. This work highlights his contributions to characterizing regional cancer patterns, improving early detection strategies, and tailoring treatment approaches. Beyond this landmark study, Choi has been instrumental in advancing biomarker research and clinical trial design, bridging the gap between molecular discoveries and real-world patient care. His impact is evident in the growing body of literature that cites his work, influencing both national health policies and international lung cancer guidelines. For students and researchers, Choi’s career exemplifies how focused, region-specific research can drive global progress in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Lung Cancer in Korea
11 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Asan Medical Center

Top Papers

  1. 1
    Lung Cancer in Korea
    11 citations · 2021

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago